Skip to content
AnalystLens

Exelixis 8-K Report, Executive Changes (Jun 3, 2024)

Reports
Leadership Changes·Shareholder Matters
Filing Date
Filed June 3, 2024
Period End
May 30, 2024
Security
EXEL
In the record · 2016–202610-K1110-Q358-K119

EXEL filed 11 annual reports (10-K), 35 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jul ’17Jul ’17
  2. Material agreement8-K · Dec ’19Dec ’19
  3. Leadership change8-K · May ’22May ’22
  4. Leadership change8-K · May ’26May ’26

Summary

Summary of the 8-K filed June 3, 2024. Cited figures are marked; the original filing is the authoritative source.

Exelixis, Inc. filed this Current Report on Form 8-K to report the results of its 2024 Annual Meeting of Stockholders, held May 30, 2024 via live webcast.

The filing discloses two items: Item 5.02 and Item 5.07. The main action was stockholder approval of an amendment and restatement of the Exelixis, Inc. 2000 Employee Stock Purchase Plan (the Amended ESPP), which took effect immediately upon approval. The amendment was made primarily to increase the number of shares of common stock authorized for issuance under the plan by 6,000,000 shares.

The filing states that the material terms are summarized in the definitive proxy statement filed April 18, 2024, and that the Amended ESPP is filed as Appendix A to that proxy statement. Stockholders also elected 11 directors to serve until the 2025 annual meeting, ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending January 3, 2025, and approved, on an advisory basis, the compensation of the named executive officers (Say on Pay). Each proposal was approved, with vote counts for and against reported in the filing.

Key Highlights

  1. Stockholders approved the amended and restated 2000 Employee Stock Purchase Plan, effective immediately on May 30, 2024.
  2. The ESPP amendment primarily increases the authorized common stock available for issuance under the plan by 6,000,000 shares.
  3. Eleven directors were elected to serve until the 2025 annual meeting; Mary C. Beckerle, Ph.D. received 234,784,699 votes FOR, the highest support among the nominees' FOR tallies listed alongside David E. Johnson at 234,906,753, and S. Gail Eckhardt, M.D. at 235,689,633.
  4. Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending January 3, 2025, with 254,624,587 votes FOR and 6,793,128 AGAINST.
  5. The Say on Pay advisory proposal on named executive officer compensation was approved, with 226,652,255 votes FOR and 9,785,746 AGAINST.
  6. The 2024 Annual Meeting proxy statement, filed April 18, 2024, contains the full summary of the Amended ESPP terms, which is also filed as Appendix A to that proxy statement.
  7. Broker non-votes of 26,521,398 were recorded for the director elections, ESPP approval, and Say on Pay proposals.

Frequently Asked Questions

  1. What did Exelixis stockholders approve regarding the employee stock purchase plan?

    Stockholders approved an amendment and restatement of the Exelixis, Inc. 2000 Employee Stock Purchase Plan, which became effective immediately upon approval at the May 30, 2024 Annual Meeting. The main change increases the shares of common stock authorized for issuance under the plan by 6,000,000 shares.

  2. Where can investors find the full terms of the Amended ESPP?

    The filing states that a more complete summary of the material terms is in the definitive proxy statement filed with the SEC on April 18, 2024. The full Amended ESPP text is filed as Appendix A to that proxy statement.

  3. Who was elected to the board, and for how long?

    Eleven directors were elected, including Mary C. Beckerle, Ph.D., S. Gail Eckhardt, M.D., Maria C. Freire, Ph.D., Tomas J. Heyman, David E. Johnson, Michael M. Morrissey, Ph.D., Robert L. Oliver, Jr., Stelios Papadopoulos, Ph.D., George Poste, DVM, Ph.D., FRS, Julie Anne Smith, and Jack L. Wyszomierski. Each will serve until the 2025 annual meeting and until a successor is elected and qualified, or until earlier death, resignation, or removal.

  4. Which independent accounting firm did stockholders ratify?

    Stockholders ratified Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 3, 2025. The vote was 254,624,587 FOR, 6,793,128 AGAINST, and 2,008,818 ABSTAIN.